[Research progress of GNAQ/GNA11-related capillary malformation spectrum]
1Department of Dermatology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100020, China.
Insights
Capillary malformations (CM) are common vascular issues. This review details recent advancements in understanding and treating CM-related syndromes caused by GNAQ/GNA11 gene mutations.
Area of Science:
- Genetics
- Dermatology
- Vascular Biology
Background:
- Capillary malformations (CM) are the most frequent vascular malformations, presenting diverse clinical needs.
- CM-related syndromes, often linked to somatic GNAQ/GNA11 mutations, complicate diagnosis and treatment due to varied presentations.
Purpose of the Study:
- To provide an overview of recent research on GNAQ/GNA11-related capillary malformation diseases.
- To comprehensively discuss pathogenic mechanisms, clinical features, and therapeutic strategies for these conditions.
Main Methods:
- Literature review of recent advancements in GNAQ/GNA11-related capillary malformation research.
- Synthesis of information on disease mechanisms, clinical manifestations, and treatment outcomes.
Main Results:
- GNAQ/GNA11 mutations are central to a spectrum of CM-related disorders.
- These syndromes exhibit significant variability in clinical presentation and treatment response.
- Understanding these variations is crucial for effective clinical management.
Conclusions:
- Further research is needed to develop standardized diagnostic and treatment protocols.
- Targeted therapies addressing GNAQ/GNA11 pathways show promise.
- Multidisciplinary approaches are essential for managing complex CM-related syndromes.
Abstract:
Capillary malformations (CM), the most common type of vascular malformations, has a wide range of clinical needs for diagnosis and treatment. In-depth research and effective management strategies need to be developed for this disease. Beyond the simplex forms of CM, there exists a broad category of disorders manifested as CM-related syndromes, closely associated with somatic mutations in the GNAQ and GNA11 genes. These diseases present numerous commonalities and differences in clinical manifestations, associated symptoms, and management outcomes, posing challenges for clinical diagnosis, differential diagnosis, and standardized treatment. Considering this, this article aims to provide an overview of the latest research advancements in the spectrum of GNAQ/GNA11 related capillary malformation diseases, offering a comprehensive summary and in-depth discussion of their pathogenic mechanisms, clinical presentations, and treatment options.
